Pregnancy during Ustekinumab Treatment for Severe Psoriasis

被引:37
|
作者
Rocha, Katiucia [1 ]
Piccinin, Mariana Carolina [1 ]
Kalache, Luciana F. [1 ]
Reichert-Faria, Adriane [1 ]
Silva de Castro, Caio Cesar [1 ]
机构
[1] PUCPR, Hosp Santa Casa Curitiba, Dept Dermatol, Curitiba, Parana, Brazil
关键词
Psoriasis; Pregnancy; Ustekinumab; OUTCOMES; WOMEN; TNF;
D O I
10.1159/000380880
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report the case of a 25-year-old patient who became pregnant during ustekinumab therapy. Treatment was suspended immediately after pregnancy had been confirmed. The patient had an uneventful pregnancy and her child is currently 14 months old, with adequate development to her age. Four reports of pregnancy during ustekinumab treatment have been reported and one resulted in miscarriage. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:103 / 104
页数:2
相关论文
共 50 条
  • [1] Treatment of Severe Psoriasis With Ustekinumab During Pregnancy
    Andrulonis, Ryan
    Ferris, Laura Korb
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (10) : 1240 - 1241
  • [2] Ustekinumab for the treatment of moderate to severe psoriasis
    Gospodarevskaya, E.
    Picot, J.
    Cooper, K.
    Loveman, E.
    Takeda, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 61 - 66
  • [3] Successful Treatment of Severe Psoriasis in an Adolescent with Ustekinumab
    AbuHilal, Mohn'd
    Ho, Nhung
    PEDIATRIC DERMATOLOGY, 2015, 32 (03) : 377 - 380
  • [4] Case of recurrent severe cellulitis and cutaneous candidiasis during psoriasis treatment with ustekinumab
    Miyachi, Hideaki
    Nakamura, Yuumi
    Wakabayashi, Seiichiro
    Iwasawa, Mari Takahashi
    Oikawa, Ayako
    Watanabe, Akira
    Matsue, Hiroyuki
    JOURNAL OF DERMATOLOGY, 2017, 44 (08): : E206 - E207
  • [5] Amelanotic melanoma during the use of ustekinumab for severe psoriasis
    da Silva, Felipe Ribeiro
    Filgueiras de Souza, Claudio Lelis
    Steiner, Denise
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB38 - AB38
  • [6] Efficacy of Ustekinumab in the Treatment of Moderate-Severe Psoriasis
    Jimenez-Puya, R.
    Moreno, J. C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 : 16 - 24
  • [7] Ustekinumab in the treatment of severe rupioid psoriasis: A case report
    Necas, M.
    Vasku, V.
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2010, 19 (02): : 23 - 27
  • [8] Severe disseminated Nocardia infection associated with ustekinumab treatment for psoriasis
    Couture-Cossette, A.
    Morand, M.
    Vinh, D. C.
    Gratton, M.
    Martin, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (01) : 194 - 195
  • [9] Ustekinumab and TNF-inhibitors in the treatment of moderate to severe psoriasis
    Garcia Lopez, Isabel
    Herranz Alonso, Ana
    Rodriguez Gonzalez, Carmen Guadelupe
    Castillo Romera, Isabel
    Pernia Lopez, Sagrario
    Sanjurjo Saez, M.
    EJHP PRACTICE, 2011, 17 (01): : 46 - 50
  • [10] COST EFFECTIVENESS OF TREATMENT WITH ETANERCEPT OR USTEKINUMAB FOR MODERATE TO SEVERE PSORIASIS
    Villacorta, R.
    Hay, J.
    Messali, A.
    VALUE IN HEALTH, 2012, 15 (04) : A103 - A103